Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalena Wysocka

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Current Pharmaceutical Design|September 29, 2012
Future of protease activity assaysMagdalena Wysocka, Adam Lesner
Acta Biochimica Polonica|August 30, 2021
Evaluating the antibacterial activity of muramyl dipeptide derivatives, retro-tuftsin derivatives, and anthraquinone oligopeptides against a range of pathogenic bacteriaMagdalena Wysocka, Krystyna Dzierzbicka, Beata Krawczyk
Current Pharmaceutical Design|December 30, 2011
Sunflower trypsin inhibitor 1 as a molecular scaffold for drug discoveryAdam Lesner, Anna Łęgowska, Magdalena Wysocka, et al.
Frontiers in Cellular and Infection Microbiology|May 9, 2022
Urinary Tract Infections Caused by <i>K. pneumoniae</i> in Kidney Transplant Recipients - Epidemiology, Virulence and Antibiotic ResistanceBeata Krawczyk, Magdalena Wysocka, Michał Michalik, et al.
Developmental Period Medicine|August 30, 2014
Eating habits of patients with cleft lip and palate terated with fixed appliancesMagdalena Wysocka, Dorota Cudziło, Beata Kawala, et al.
Analytical Biochemistry|October 2, 2023
Optimization of fluorescent substrates for ADAM17 and their utility in the detection of diabetesHonorata Sikora, Natalia Gruba, Magdalena Wysocka, et al.
Protein and Peptide Letters|June 8, 2012
Pegylated fluorescent peptides as substrates of proteolytic enzymesMagdalena Wysocka, Adam Lesner, Jadwiga Popow, et al.
Bioorganic & Medicinal Chemistry|April 14, 2009
Introduction of non-natural amino acid residues into the substrate-specific P1 position of trypsin inhibitor SFTI-1 yields potent chymotrypsin and cathepsin G inhibitorsAnna Łegowska, Dawid Debowski, Adam Lesner, et al.
Protein and Peptide Letters|April 10, 2009
Low-molecular-weight aldehyde inhibitors of cathepsin GAdam Lesner, Magdalena Wysocka, Marta Solek, et al.
Molecular Diversity|April 10, 2009
Selection of peptomeric inhibitors of bovine alpha-chymotrypsin and cathepsin G based on trypsin inhibitor SFTI-1 using a combinatorial chemistry approachAnna Łegowska, Dawid Debowski, Adam Lesner, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Current Pharmaceutical Design|September 29, 2012
Future of protease activity assaysMagdalena Wysocka, Adam Lesner
Acta Biochimica Polonica|August 30, 2021
Evaluating the antibacterial activity of muramyl dipeptide derivatives, retro-tuftsin derivatives, and anthraquinone oligopeptides against a range of pathogenic bacteriaMagdalena Wysocka, Krystyna Dzierzbicka, Beata Krawczyk
Current Pharmaceutical Design|December 30, 2011
Sunflower trypsin inhibitor 1 as a molecular scaffold for drug discoveryAdam Lesner, Anna Łęgowska, Magdalena Wysocka, et al.
Frontiers in Cellular and Infection Microbiology|May 9, 2022
Urinary Tract Infections Caused by <i>K. pneumoniae</i> in Kidney Transplant Recipients - Epidemiology, Virulence and Antibiotic ResistanceBeata Krawczyk, Magdalena Wysocka, Michał Michalik, et al.
Developmental Period Medicine|August 30, 2014
Eating habits of patients with cleft lip and palate terated with fixed appliancesMagdalena Wysocka, Dorota Cudziło, Beata Kawala, et al.
Analytical Biochemistry|October 2, 2023
Optimization of fluorescent substrates for ADAM17 and their utility in the detection of diabetesHonorata Sikora, Natalia Gruba, Magdalena Wysocka, et al.
Protein and Peptide Letters|June 8, 2012
Pegylated fluorescent peptides as substrates of proteolytic enzymesMagdalena Wysocka, Adam Lesner, Jadwiga Popow, et al.
Bioorganic & Medicinal Chemistry|April 14, 2009
Introduction of non-natural amino acid residues into the substrate-specific P1 position of trypsin inhibitor SFTI-1 yields potent chymotrypsin and cathepsin G inhibitorsAnna Łegowska, Dawid Debowski, Adam Lesner, et al.
Protein and Peptide Letters|April 10, 2009
Low-molecular-weight aldehyde inhibitors of cathepsin GAdam Lesner, Magdalena Wysocka, Marta Solek, et al.
Molecular Diversity|April 10, 2009
Selection of peptomeric inhibitors of bovine alpha-chymotrypsin and cathepsin G based on trypsin inhibitor SFTI-1 using a combinatorial chemistry approachAnna Łegowska, Dawid Debowski, Adam Lesner, et al.
Pageof 8